Investor insights
Sectors invested in
Funding rounds participated in
$3M sweet spot round size
Most of their 27 investments are in rounds between $30M and $85M
Investor type
Basic info
Industry
Date founded
2020
Investments made
ReCode Therapeutics raised $50M on September 19, 2023
Investors: Sanofi Ventures, OrbiMed Advisors, Vida Ventures, LLC, Leaps by Bayer, Osage University Partners (OUP), MPM Capital and Solasta Ventures
BOXHUB raised $12M on June 28, 2023
Investors: AlleyCorp, Interplay, FJ Labs, Captec.io and Solasta Ventures
Prime Roots raised $30M on May 15, 2023
Investors: The House Fund, Pangaea Ventures, Portfolia, True Ventures, Monde Nissin Corporation, Prosus Group, Top Tier Capital Partners, SOSV - The Accelerator VC and Solasta Ventures
Ensoma raised $85M on January 5, 2023
Investors: Qatar Investment Authority, Mirae Asset MAPS Global Investments Co., Ltd, fred hutch, Viking Global Investors, Takeda UK Limited, F-Prime Capital Partners, Catalio Capital Management, - and Solasta Ventures
Carisma Therapeutics raised $30M on September 21, 2022
Investors: Agent Capital, Wellington Partners, HealthCap, Livzon and Solasta Ventures
Tibit Communications, Inc. raised $30M on June 23, 2022
Investors: Swisscom Ventures, Juniper Networks, Ciena, Liberty Global, Intel Capital and Solasta Ventures
Carbon Biosciences raised $38M on June 21, 2022
Investors: Astellas Venture Capital L.L.C., Longwood Fund, Camford Capital, UTokyo Innovation Platform Co., Ltd., Agent Capital and Solasta Ventures
Soul Machines raised $70M on February 14, 2022
Investors: SoftBank Investment Advisers, Temasek, Salesforce Ventures, Cleveland Avenue, Horizons Ventures, Liberty City Ventures and Solasta Ventures
Rescale raised $55M on November 23, 2021
Investors: 深圳水木易德投资管理合伙企业(有限合伙), M12 - Microsoft's Venture Fund, 普思投资, Nautilus Venture Partners, Republic Capital and Solasta Ventures
Immunitas Therapeutics raised $58M on August 18, 2021
Investors: NS Investment, M Ventures, The Leukemia & Lymphoma Society, Mirae Asset MAPS Global Investments Co., Ltd, Longwood Fund, Medical Excellence Capital, LLC and Solasta Ventures